Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates

Mashaal Dhir; Chandrakanth Are

doi:10.1245/s10434-020-09474-7

Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1871-1873
Number of pages	3
Journal	Annals of Surgical Oncology
Volume	28
Issue number	4
DOIs	https://doi.org/10.1245/s10434-020-09474-7
State	Published - Apr 2021

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-020-09474-7

Cite this

@article{a1ba08293f1046aeb65d13b5641fa48d,

title = "Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates",

author = "Mashaal Dhir and Chandrakanth Are",

year = "2021",

month = apr,

doi = "10.1245/s10434-020-09474-7",

language = "English (US)",

volume = "28",

pages = "1871--1873",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "4",

}

TY - JOUR

T1 - Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer

T2 - Reduction in Postoperative Readmission Rates

AU - Dhir, Mashaal

AU - Are, Chandrakanth

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85098783789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098783789&partnerID=8YFLogxK

U2 - 10.1245/s10434-020-09474-7

DO - 10.1245/s10434-020-09474-7

M3 - Editorial

C2 - 33389295

AN - SCOPUS:85098783789

SN - 1068-9265

VL - 28

SP - 1871

EP - 1873

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 4

ER -

Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this